Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach

INTRODUCTION: An estimated 69 million traumatic brain injuries (TBI) occur each year worldwide, with most in low-income and middle-income countries. The CRASH-3 randomised trial found that intravenous administration of tranexamic acid within 3 hours of injury reduces head injury deaths in patients s...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Jack, Roberts, Ian, Shakur-Still, Haleema, Lecky, Fiona E, Chaudhri, Rizwana, Miners, Alec
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470492/
https://www.ncbi.nlm.nih.gov/pubmed/32878899
http://dx.doi.org/10.1136/bmjgh-2020-002716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470492/
https://www.ncbi.nlm.nih.gov/pubmed/32878899
http://dx.doi.org/10.1136/bmjgh-2020-002716

Ejemplares similares